Weakly immunogenic tumours may have an insufficiently active T-cell population to respond to PD-1/PD-L1 blockade; additionally, potentially immunogenic tumours will also be resistant to PD-1/PD-L1 blockade if they develop mechanisms to suppress the activation and infiltration of T-cells after the treatment. The gene discussed is CD274; the disease is neoplasm.